Trials Designed and Executed by the Allegretti Lab
CP101 for the Treatment of Ulcerative Colitis
Stool Donor Body Mass Index Does Not Affect Recipient Weight After a Single Fecal Microbiota Transplantation for Clostridium difficile Infection
Low-Dose Interleukin 2 for the Treatment of Moderate to Severe Ulcerative Colitis
Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis:
A Pilot Clinical Trial
Outcomes After Fecal Microbiota Transplantation in Combination With Bezlotoxumab for Inflammatory Bowel Disease and Recurrent Clostridioides difficile Infection